Ergoteles’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Ergoteles’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-135,323	Closed	-$298K	–	2244
2022 Q2	$298K	Buy	+135,323	New	+$270K	0.01%	1112

Ergoteles's ETTX Position: Q3 2022 in Review

Ergoteles sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 135,323 shares — an estimated $298K sold.

Ergoteles first reported a position in ETTX in Q2 2022 and held it in 1 quarter. The position peaked at $298K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Ergoteles reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 135,323 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $298K.
Ergoteles first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2022 and held it in 1 quarter.
Ergoteles's Entasis Therapeutics Holdings Inc. position peaked at $298K in Q2 2022.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.